Abstract: The present invention is directed to an artificial nucleic acid and to a polypeptide suitable for use in the treatment or prophylaxis of an infection with a flavivirus, in particular an infection with yellow fever virus or with dengue virus, or of a disorder related to such an infection. The present invention is also directed to a composition, preferably an immunogenic composition, comprising the artificial nucleic acid or the inventive polypeptide. In particular, the present invention concerns an immunogenic composition against a flavivirus, such as yellow fever virus or dengue virus. Further, the invention concerns a kit, particularly a kit of parts, comprising the artificial nucleic acid, polypeptide or (immunogenic) composition.

Abstract: The present invention is directed to an artificial nucleic acid and to a polypeptide suitable for use in the treatment or prophylaxis of an infection with a flavivirus, in particular an infection with yellow fever virus or with dengue virus, or of a disorder related to such an infection. The present invention is also directed to a composition, preferably an immunogenic composition, comprising the artificial nucleic acid or the inventive polypeptide. In particular, the present invention concerns an immunogenic composition against a flavivirus, such as yellow fever virus or dengue virus. Further, the invention concerns a kit, particularly a kit of parts, comprising the artificial nucleic acid, polypeptide or (immunogenic) composition.

Abstract: An interface is for connecting a first electronic component to a network of a plurality of electronic components. The first electronic component is implemented as a telecommunication terminal. A second electronic component connected to the network is implemented as a reproduction or processing device for data of the telecommunication terminal. The interface transmits the data between the reproduction or processing device and the telecommunication terminal.

Abstract: An interface is for connecting a first electronic component to a network of a plurality of electronic components. The first electronic component is implemented as a telecommunication terminal. A second electronic component connected to the network is implemented as a reproduction or processing device for data of the telecommunication terminal. The interface transmits the data between the reproduction or processing device and the telecommunication terminal.

Abstract: A device for recording the fill level of a liquid inside a container in which an elongated, flexible tubular electrical contact element is arranged, one end area of which is provided with connections at which an electrical signal can be measured. Electrically conductive coatings are disposed on the inner surface of the contact element and facing towards one another, which coatings may be brought into contact with one another by means of a contact producing acquisition element which is disposed on the outside and is movable relative to the flexible contact element.

Abstract: A device for recording the fill level of a liquid inside a container in which an elongated, flexible tubular electrical contact element is arranged, one end area of which is provided with connections at which an electrical signal can be measured. Electrically conductive coatings are disposed on the inner surface of the contact element and facing towards one another, which coatings may be brought into contact with one another by means of a contact producing acquisition element which is disposed on the outside and is movable relative to the flexible contact element.

Abstract: A device is proposed for ascertaining distance and transmitting data in a motor vehicle. It has a transmitting arrangement for generating and emitting a radar signal. A receiving arrangement receives a radar signal. It is characterized in that switchover arrangements are provided which cause the transmitting and/or receiving arrangement to operate either in a radar operating mode for detecting the distance and/or speed of a further object, or in a data-exchange operating mode for the exchange of data with a transceiver. Specific functions are enabled in dependence on the data exchange.

Abstract: These invention relates to metal-complexing, cysteine-free peptides which may be coupled to an organ-specific probe directly or via a linker and are thus enriched as conjugates specifically in tumors, organs, tissues or centers of inflammation. The organ-specific probes used are, for example, antibodies or part-sequences of antibodies against tumor-associated antigens, e.g. the carcino-embryonal antigen (CEA, which are thus specifically enriched in tumors. The invention also relates to processes for producing the metal-complexing cysteine-free peptides and their conjugates. The present invention also relates to the use of the conjugates as components of a kit for in vivo diagnosis or in vivo therapy and radio-pharmaceuticals containing these conjugates together with radio-isotopes. The organ-specific conjugates are used to image tumors, organs or centers of inflammation.

Abstract: This invention relates to new bifunctional chelating agents with intermittent chalcogen atoms, pharmaceuticals containing these compounds, their use in radiodiagnostics and radiotherapy, and methods for the production of these compounds.The compound according to the invention has the general formula (I)M--Lwherein M represents a radionuclide of Tc or Re and L a ligand of the general formula (II)B--CO--CR.sup.1 R.sup.2 --A--CR.sup.3 R.sup.4 --CO--D (II)These new, bifunctional chelating agents with intermittent chalcogen atoms and their coupling products with compounds that accumulate specifically are suited for producing radiopharmaceuticals for diagnostic and therapeutic purposes.

Abstract: This invention relates to new bifunctional chelating agents with intermittent chalcogen atoms, pharmaceuticals containing these compounds, their use in radiodiagnostics and radiotherapy, and methods for the production of these compounds.The compound according to the invention has the general formula (I)M--Lwhere M represents a radionuclide and L a ligand of the general formula (II).It was found, surprisingly, that these new, bifunctional chelating agents with intermittent chalcogen atoms and their coupling products with compounds that accumulate specifically are excellently suited for producing radiopharmaceuticals for diagnostic and therapeutic purposes.

Abstract: The invention relates to compounds having the general formula I ##STR1## where A if required can contain a functional and/or activated group C for coupling to selectively concentrating compounds or can contain a selectively concentrating compound coupled via the group C. B and B' are functional groups for coordinate bonding of groups carrying metal ions. The novel compounds are for forming complexes with radioactive metal ions, more particularly rhenium and technetium isotopes, and are used in medical diagnosis and therapy.